GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr | ₹1,678 Cr |
What is the latest Total Expenditure of GLAND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹4,332 Cr |
| Mar2024 | ₹2,600 Cr |
| Mar2023 | ₹2,891 Cr |
| Mar2022 | ₹2,161 Cr |
| Mar2021 | ₹1,678 Cr |
How is Total Expenditure of GLAND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,332 Cr | 66.61 | |
| Mar2024 | ₹2,600 Cr | -10.06 | |
| Mar2023 | ₹2,891 Cr | 33.78 | |
| Mar2022 | ₹2,161 Cr | 28.78 | |
| Mar2021 | ₹1,678 Cr | - | |
Compare Total Expenditure of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹40,598.3 Cr | 3.7% | 10.2% | 36.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.7% |
10.2% |
36.4% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses